[Multimodality treatment concepts for metastatic breast cancer].
While metastatic breast cancer is a systemic disease in most patients, there is a smaller subset of patients who suffer from oligometastatic disease defined by single or few resectable metastases. After verification of disease stabilization by systemic therapy, locoregional treatment such as surgery or radiation can be applied. While large prospective trials are missing to support the beneficial effect of this strategy, retrospective analyses are highly suggestive offering rapid disease control and even long-term survival in selected patients.
Medizinische Klinik und Poliklinik III, Comprehensive Cancer Center LMU, Klinikum der Universität München, Marchioninistraße 15, 81377, München. Volker.Heinemann@med.uni-muenchen.de
V
V
Heinemann
S
S
Kahlert
H-J
HJ
Stemmler
D001859:Bone Neoplasms / Q000401:mortality / Q000473:pathology / Q000556:secondary / Q000628:therapy; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D003952:Diagnostic Imaging; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000556:secondary / Q000628:therapy; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000556:secondary / Q000628:therapy; D008207:Lymphatic Metastasis / Q000473:pathology; D009367:Neoplasm Staging; D010534:Peritoneal Neoplasms / Q000401:mortality / Q000473:pathology / Q000556:secondary / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate